Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.12USD
8:59pm BST
Change (% chg)

$-0.09 (-42.86%)
Prev Close
$0.20
Open
$0.10
Day's High
$0.12
Day's Low
$0.10
Volume
11,714,234
Avg. Vol
111,656
52-wk High
$2.56
52-wk Low
$0.10

About

ContraVir Pharmaceuticals, Inc. is focused on curing hepatitis B through the combination of direct and indirect acting antiviral compounds. Its two assets tenofovir exalidex, or TXL, and CRV431 have complementary mechanisms of action and have shown potential synergy against hepatitis B virus (HBV). TXL is designed to deliver... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 78.00
Dividend: --
Yield (%): --

Financials

  CTRV.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.29 -- --
ROI: -126.93 8.91 13.83
ROE: -- 10.06 15.25

Earnings vs. Estimates